AARTIDRUGS — Aarti Drugs Income Statement

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapNeutral

Annual income statement for Aarti Drugs, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	IAS	IAS	IAS	IAS	—
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	21,548	24,886	27,161	25,286	23,870
Cost of Revenue
Gross Profit	6,155	5,212	5,146	5,316	8,449
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	17,673	22,061	24,569	22,590	21,558
Operating Profit	3,875	2,825	2,591	2,696	2,313
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	3,690	2,700	2,242	2,355	2,118
Provision for Income Taxes
Net Income After Taxes	2,804	2,050	1,664	1,716	1,681
Minority Interest
Net Income Before Extraordinary Items
Net Income	2,804	2,050	1,663	1,714	1,682
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	2,804	2,050	1,663	1,714	1,682
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	30.1	22.1	18	18.7	18.4
Dividends per Share